In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Prevention of CVD Programme

Preventive Cardiology
Risk Factors and Prevention

The ESC Prevention of CVD Programme (2015-2020) was conducted by the EAPC to promote effective secondary prevention among those with risk factors as well as those that survived a clinical event.

Led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Association for Acute CardioVascular Care (ACVC) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) it included access to educational and scientific resources on ischaemic heart disease and treatment goals, cardiovascular risk assessment and management tools, as well as cardiac rehabilitation and exercise training recommendations.

  • Phase I: Secondary Prevention after Myocardial Infarction 
    Understanding the needs – Evaluating gaps in knowledge & adherence to treatment: literature review, health professional survey and awareness initiative.
  • Phase II: Focus on Secondary Prevention 
    Development of educational programme and tools for improved management of high-risk patients and patients after acute coronary syndromes: scientific resources, educational activities, and practical tools.
  • Phase III: Continued Roll-out, Evaluation and Follow-up

Through this programme, the EAPC produced key recommendations on secondary prevention post MI based on a literature review, issued a summary report from the Health Professional Survey conducted to identify perceived barriers to implementation, published a consensus document on the Challenges in Secondary Prevention after Acute Myocardial Infarction (EJPC, published online on 7 Sept 2016) and published an Educational Paper on Risk Prediction Tools as well as a Supplement Essentials of Secondary Prevention published in the European Journal of Preventive Cardiology (EJPC). A European Summit on CVD Prevention was held in 2019 at the European Heart House in Sophia Antipolis, France. 

The ESC Prevention of Cardiovascular Disease programme was supported by AMGEN, AstraZeneca, Ferrer for good, and Sanofi and Regeneron in the form of educational grants.